News
Roche Looks to Expand its Drug Production in the US
Roche is planning to expand its drug production in the US and has announced a pledge to spend $50 billion in the next five years on new as well as existing manufacturing facilities across several states.
This investment promise is...
News
How Language Barriers Impact Non-Native English Speakers in Healthcare
Language barriers create significant challenges for non-native English speakers in healthcare settings. In the United States, English is the primary language, which complicates communication for non-English-speaking patients.Â
These patients often struggle to describe symptoms, understand instructions, and navigate the healthcare...
Clinical Trials
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics, has announced U.S. FDA approval of AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy associated with wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. This approval makes AMVUTTRA the first and...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data from the B1 cohort of the trial showed encouraging antitumor efficacy in highly pre-treated...
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support
European life sciences investment firm Sofinnova Partners has announced the final close of its second biotech acceleration fund, raising €165 million and surpassing its original target. The fund, Sofinnova...
News
The Best Type of Accreditation for a Telehealth Provider
Telehealth and remote patient monitoring services are becoming more prominent throughout the world. However, as more health care providers aim to deliver assistance through this medium, it is important to maintain quality, safety and effectiveness. The right accreditation or...
BioPharma
Pharmaceutical Contract Sales Market to Hit $26.24B by 2034
Contract Sales Organizations: Transforming Pharma Companies
Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing costs low. These organizations happen to offer experts who work alongside pharmaceutical companies in order...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read